The tyrosine kinase inhibitor STI571, like interferon-α, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia
Year: 2000
Type: article
Source: Experimental Hematology
Authors: Stephen B Marley, Michael W.N Deininger, R.John Davidson, John M Goldman, Myrtle Y Gordon
Institutions: Hammersmith Hospital, Imperial College London
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2050146687